The LymeX Authorization Act authorizes the Secretary of Health and Human Services to spend up to $5 million on prize competitions designed to speed up innovation in preventing, diagnosing, and treating Lyme disease. These competitions would engage a broad range of participants including universities, nonprofits, private companies, small businesses, and entrepreneurs to develop new solutions. The bill reflects a policy commitment to improve Lyme disease care through better health education, patient awareness, and next-generation diagnostic tools that are faster and more patient-focused. The bill does not specify a completion timeline but provides the funding authority needed to launch these innovation competitions. This approach uses financial incentives to encourage breakthrough developments from diverse stakeholders across the public and private sectors.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.